Review paper
Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
Abstract
Today there is plausible evidence both on experimental and epidemiological basis, that hyperuricemia represents a risk factor for the development and progression of chronic kidney disease (CKD). Nevertheless, the role of serum uric acid lowering treatment in CKD is still a matter of serious controversy. Review of randomised controlled trials, suggests that there may be an improvement of renal function with allopurinol treatment in CKD stage 3–5....
Paper Details
Title
Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
Published Date
Sep 1, 2017
Journal
Volume
8
Issue
5
Pages
555 - 560
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History